Sébastien Simoncelli
@ssimoncellimwtc.bsky.social
I help life sciences founders to generate more impactful opportunities on Bluesky.
Founder’s Checklist: 5 Things to Post This Month
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
August 22, 2025 at 12:02 PM
Founder’s Checklist: 5 Things to Post This Month
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
Bluesky Engagement & Science Communication
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
August 22, 2025 at 7:02 AM
Bluesky Engagement & Science Communication
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
Breaking Down Regulatory Wins
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
August 21, 2025 at 12:02 PM
Breaking Down Regulatory Wins
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
Why Bluesky is Perfect for Life Sciences Thought Leadership?
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
August 21, 2025 at 7:02 AM
Why Bluesky is Perfect for Life Sciences Thought Leadership?
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
Funding News Isn’t Enough.
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
August 20, 2025 at 12:02 PM
Funding News Isn’t Enough.
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
What Bluesky Teaches Founders About Trust?
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
August 20, 2025 at 7:02 AM
What Bluesky Teaches Founders About Trust?
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
Way to Make Complex Science Engaging
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
August 19, 2025 at 12:03 PM
Way to Make Complex Science Engaging
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
How to Share Clinical Milestones on Bluesky
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
August 19, 2025 at 7:14 AM
How to Share Clinical Milestones on Bluesky
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
Bluesky vs LinkedIn: Where Should Founders Focus?
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
August 18, 2025 at 12:02 PM
Bluesky vs LinkedIn: Where Should Founders Focus?
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
Why Founders Struggle with Translating Science to Social Media?
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech
August 18, 2025 at 7:02 AM
Why Founders Struggle with Translating Science to Social Media?
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech
3 questions to ask before every post:
- Will this teach my audience something new?
- Could this spark a comment or DM?
- Does this show my thinking clearly?
If yes to all three, it’s a lead magnet.
- Will this teach my audience something new?
- Could this spark a comment or DM?
- Does this show my thinking clearly?
If yes to all three, it’s a lead magnet.
August 8, 2025 at 4:02 PM
3 questions to ask before every post:
- Will this teach my audience something new?
- Could this spark a comment or DM?
- Does this show my thinking clearly?
If yes to all three, it’s a lead magnet.
- Will this teach my audience something new?
- Could this spark a comment or DM?
- Does this show my thinking clearly?
If yes to all three, it’s a lead magnet.
Old authority:
Job titles and long bios.
Polished but distant branding.
Announcements only.
New authority:
Consistent public thinking.
Sharing progress as it happens.
Showing, not telling.
Experts teach. Authorities demonstrate.
#Biotech
Job titles and long bios.
Polished but distant branding.
Announcements only.
New authority:
Consistent public thinking.
Sharing progress as it happens.
Showing, not telling.
Experts teach. Authorities demonstrate.
#Biotech
August 8, 2025 at 10:01 AM
Old authority:
Job titles and long bios.
Polished but distant branding.
Announcements only.
New authority:
Consistent public thinking.
Sharing progress as it happens.
Showing, not telling.
Experts teach. Authorities demonstrate.
#Biotech
Job titles and long bios.
Polished but distant branding.
Announcements only.
New authority:
Consistent public thinking.
Sharing progress as it happens.
Showing, not telling.
Experts teach. Authorities demonstrate.
#Biotech
5 subtle CTAs for Bluesky posts:
↳ “Ask me how we solved this”
↳ “DM if this is your challenge too”
↳ “Would love to compare notes”
↳ “Curious if anyone else has tried this”
↳ “If you’re working on X, let’s talk”
#LifeSciences
↳ “Ask me how we solved this”
↳ “DM if this is your challenge too”
↳ “Would love to compare notes”
↳ “Curious if anyone else has tried this”
↳ “If you’re working on X, let’s talk”
#LifeSciences
August 7, 2025 at 4:02 PM
5 subtle CTAs for Bluesky posts:
↳ “Ask me how we solved this”
↳ “DM if this is your challenge too”
↳ “Would love to compare notes”
↳ “Curious if anyone else has tried this”
↳ “If you’re working on X, let’s talk”
#LifeSciences
↳ “Ask me how we solved this”
↳ “DM if this is your challenge too”
↳ “Would love to compare notes”
↳ “Curious if anyone else has tried this”
↳ “If you’re working on X, let’s talk”
#LifeSciences
Want to turn comments into leads?
✅ Answer industry questions directly.
✅ Share small, specific examples.
✅ Ask follow-up questions that spark DM chats.
👉 Leads start in public, then move to private.
✅ Answer industry questions directly.
✅ Share small, specific examples.
✅ Ask follow-up questions that spark DM chats.
👉 Leads start in public, then move to private.
August 7, 2025 at 10:02 AM
Want to turn comments into leads?
✅ Answer industry questions directly.
✅ Share small, specific examples.
✅ Ask follow-up questions that spark DM chats.
👉 Leads start in public, then move to private.
✅ Answer industry questions directly.
✅ Share small, specific examples.
✅ Ask follow-up questions that spark DM chats.
👉 Leads start in public, then move to private.
Leads don’t appear out of nowhere.
On Bluesky, they come from visibility.
Share your thinking, your challenges, and your niche expertise.
The more people see your mind at work, the more likely they’ll trust you enough to start a conversation.
#biotechnetworking
On Bluesky, they come from visibility.
Share your thinking, your challenges, and your niche expertise.
The more people see your mind at work, the more likely they’ll trust you enough to start a conversation.
#biotechnetworking
August 6, 2025 at 4:02 PM
Leads don’t appear out of nowhere.
On Bluesky, they come from visibility.
Share your thinking, your challenges, and your niche expertise.
The more people see your mind at work, the more likely they’ll trust you enough to start a conversation.
#biotechnetworking
On Bluesky, they come from visibility.
Share your thinking, your challenges, and your niche expertise.
The more people see your mind at work, the more likely they’ll trust you enough to start a conversation.
#biotechnetworking
3 mistakes life sciences founders make on Bluesky:
❌ Posting company updates only.
❌ Ignoring niche conversations.
❌ Treating it like LinkedIn 2.0
The fix?
Show up as a scientist first, founder second.
People follow expertise, not press releases.
#StartupTips
❌ Posting company updates only.
❌ Ignoring niche conversations.
❌ Treating it like LinkedIn 2.0
The fix?
Show up as a scientist first, founder second.
People follow expertise, not press releases.
#StartupTips
August 6, 2025 at 10:02 AM
3 mistakes life sciences founders make on Bluesky:
❌ Posting company updates only.
❌ Ignoring niche conversations.
❌ Treating it like LinkedIn 2.0
The fix?
Show up as a scientist first, founder second.
People follow expertise, not press releases.
#StartupTips
❌ Posting company updates only.
❌ Ignoring niche conversations.
❌ Treating it like LinkedIn 2.0
The fix?
Show up as a scientist first, founder second.
People follow expertise, not press releases.
#StartupTips
Old lead generation:
Endless LinkedIn connection requests.
Cold emails that never get opened.
Generic newsletters.
New lead generation:
Posting useful insights on Bluesky.
Answering niche questions in real time.
Attracting inbound interest naturally.
Leads find you when you stop chasing.
#Biotech
Endless LinkedIn connection requests.
Cold emails that never get opened.
Generic newsletters.
New lead generation:
Posting useful insights on Bluesky.
Answering niche questions in real time.
Attracting inbound interest naturally.
Leads find you when you stop chasing.
#Biotech
August 5, 2025 at 4:03 PM
Old lead generation:
Endless LinkedIn connection requests.
Cold emails that never get opened.
Generic newsletters.
New lead generation:
Posting useful insights on Bluesky.
Answering niche questions in real time.
Attracting inbound interest naturally.
Leads find you when you stop chasing.
#Biotech
Endless LinkedIn connection requests.
Cold emails that never get opened.
Generic newsletters.
New lead generation:
Posting useful insights on Bluesky.
Answering niche questions in real time.
Attracting inbound interest naturally.
Leads find you when you stop chasing.
#Biotech
5 types of posts that generate leads for life sciences founders on Bluesky:
- Break down recent trial data.
- Explain a complex concept in 2 sentences.
- Spotlight an industry partner
- Share lessons from a failed experiment.
- Predict a small but likely market shift.
#LifeSciences
- Break down recent trial data.
- Explain a complex concept in 2 sentences.
- Spotlight an industry partner
- Share lessons from a failed experiment.
- Predict a small but likely market shift.
#LifeSciences
August 5, 2025 at 10:02 AM
5 types of posts that generate leads for life sciences founders on Bluesky:
- Break down recent trial data.
- Explain a complex concept in 2 sentences.
- Spotlight an industry partner
- Share lessons from a failed experiment.
- Predict a small but likely market shift.
#LifeSciences
- Break down recent trial data.
- Explain a complex concept in 2 sentences.
- Spotlight an industry partner
- Share lessons from a failed experiment.
- Predict a small but likely market shift.
#LifeSciences
Want to generate leads on Bluesky?
✅ Share niche insights your prospects rarely see.
✅ Comment with real expertise, not sales pitches.
✅ Join industry conversations early.
Leads follow expertise faster than any cold DM.
#leadgeneration
#biotech
#founders
✅ Share niche insights your prospects rarely see.
✅ Comment with real expertise, not sales pitches.
✅ Join industry conversations early.
Leads follow expertise faster than any cold DM.
#leadgeneration
#biotech
#founders
August 4, 2025 at 4:03 PM
Want to generate leads on Bluesky?
✅ Share niche insights your prospects rarely see.
✅ Comment with real expertise, not sales pitches.
✅ Join industry conversations early.
Leads follow expertise faster than any cold DM.
#leadgeneration
#biotech
#founders
✅ Share niche insights your prospects rarely see.
✅ Comment with real expertise, not sales pitches.
✅ Join industry conversations early.
Leads follow expertise faster than any cold DM.
#leadgeneration
#biotech
#founders
Most founders chase leads on LinkedIn because that’s where “everyone” is. But attention is noisy there. On Bluesky, your ideal partners, investors, and early adopters are easier to spot. A focused community is often worth more than a crowded one.
#lifesciences
#biotechfounders
#earlyadopters
#lifesciences
#biotechfounders
#earlyadopters
August 4, 2025 at 10:02 AM
Most founders chase leads on LinkedIn because that’s where “everyone” is. But attention is noisy there. On Bluesky, your ideal partners, investors, and early adopters are easier to spot. A focused community is often worth more than a crowded one.
#lifesciences
#biotechfounders
#earlyadopters
#lifesciences
#biotechfounders
#earlyadopters
Imagine pitching your company without any slides.
Just story, relevance, clarity.
Could you do it?
#pitchpractice
#foundermindset
#biotechclarity
Just story, relevance, clarity.
Could you do it?
#pitchpractice
#foundermindset
#biotechclarity
August 1, 2025 at 4:00 PM
Imagine pitching your company without any slides.
Just story, relevance, clarity.
Could you do it?
#pitchpractice
#foundermindset
#biotechclarity
Just story, relevance, clarity.
Could you do it?
#pitchpractice
#foundermindset
#biotechclarity
You don’t need more likes.
You need more people DMing you saying: “That post made me think.”
Optimise for impact, not applause.
#contentstrategy
#biotechfounders
#socialselling
You need more people DMing you saying: “That post made me think.”
Optimise for impact, not applause.
#contentstrategy
#biotechfounders
#socialselling
August 1, 2025 at 10:02 AM
You don’t need more likes.
You need more people DMing you saying: “That post made me think.”
Optimise for impact, not applause.
#contentstrategy
#biotechfounders
#socialselling
You need more people DMing you saying: “That post made me think.”
Optimise for impact, not applause.
#contentstrategy
#biotechfounders
#socialselling
Founders who wait for 'traction' to start posting will miss the people who could’ve helped build it.
Visibility is a growth lever.
#lifesciencemarketing
#earlystagebiotech
#foundertips
Visibility is a growth lever.
#lifesciencemarketing
#earlystagebiotech
#foundertips
July 31, 2025 at 4:02 PM
Founders who wait for 'traction' to start posting will miss the people who could’ve helped build it.
Visibility is a growth lever.
#lifesciencemarketing
#earlystagebiotech
#foundertips
Visibility is a growth lever.
#lifesciencemarketing
#earlystagebiotech
#foundertips
Biotech isn’t boring.
But the way most founders explain it is.
If your post wouldn’t make a curious 16-year-old stop scrolling, try again.
#biotechedge
#founderbranding
#communicationskill
But the way most founders explain it is.
If your post wouldn’t make a curious 16-year-old stop scrolling, try again.
#biotechedge
#founderbranding
#communicationskill
July 31, 2025 at 10:02 AM
Biotech isn’t boring.
But the way most founders explain it is.
If your post wouldn’t make a curious 16-year-old stop scrolling, try again.
#biotechedge
#founderbranding
#communicationskill
But the way most founders explain it is.
If your post wouldn’t make a curious 16-year-old stop scrolling, try again.
#biotechedge
#founderbranding
#communicationskill
Your target audience doesn’t care about your PhD.
They care if you can solve their $10M problem.
Talk to their priorities, not your credentials.
#lifesciencebiz
#founderinsight
#biotechgrowth
They care if you can solve their $10M problem.
Talk to their priorities, not your credentials.
#lifesciencebiz
#founderinsight
#biotechgrowth
July 30, 2025 at 4:02 PM
Your target audience doesn’t care about your PhD.
They care if you can solve their $10M problem.
Talk to their priorities, not your credentials.
#lifesciencebiz
#founderinsight
#biotechgrowth
They care if you can solve their $10M problem.
Talk to their priorities, not your credentials.
#lifesciencebiz
#founderinsight
#biotechgrowth